Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis

被引:35
作者
Brunner, Walter [1 ]
Widmann, Bernhard [1 ]
Marti, Lukas [1 ]
Tarantino, Ignazio [1 ,2 ]
Schmied, Bruno M. [1 ]
Warschkow, Rene [1 ,3 ]
机构
[1] Kantonsspital St Gallen, Dept Gen Visceral Endocrine & Transplantat Surg, CH-9007 St Gallen, Switzerland
[2] Heidelberg Univ, Dept Gen Abdominal & Transplant Surg, D-69120 Heidelberg, Germany
[3] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2016年 / 30卷 / 10期
关键词
Rectal cancer; Lymph node metastasis; Surveillance; Epidemiology; and End Results (SEER); TRANSANAL ENDOSCOPIC MICROSURGERY; POSTERIOR MESORECTAL RESECTION; EARLY COLORECTAL-CANCER; LOW ANTERIOR RESECTION; SHORT-TERM OUTCOMES; PHASE-III TRIAL; LOCAL EXCISION; UNITED-STATES; CARCINOMA; SURVIVAL;
D O I
10.1007/s00464-016-4759-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Local resection of early-stage rectal cancer significantly reduces perioperative morbidity compared with radical resection. Identifying patients at risk of regional lymph node metastasis (LNM) is crucial for long-term survival after local resection. Patients after oncological resection of T1 rectal cancer were identified in the Surveillance, Epidemiology, and End Results register 2004-2012. Potential predictors of LNM and its impact on cancer-specific survival were assessed in logistic and Cox regression with and without multivariable adjustment. In total, 1593 patients with radical resection of T1 rectal cancer and a minimum of 12 retrieved regional lymph nodes were identified. The overall LNM rate was 16.3 % (N = 260). A low risk of LNM was observed for small tumor size (P = 0.002), low tumor grade (P = 0.002) and higher age (P = 0.012) in multivariable analysis. The odds ratio for a tumor size exceeding 1.5 cm was 1.49 [95 % confidence interval (CI) 1.06-2.13], for G2 and G3/G4 carcinomas 1.69 (95 % CI 1.07-2.82) and 2.72 (95 % CI 1.50-5.03), and for 65- to 79-year-old and over 80-year-old patients 0.65 (95 % CI 0.43-0.96) and 0.39 (95 % CI 0.18-0.77), respectively. Five-year cancer-specific survival for patients with LNM was 90.0 % (95 % CI 85.3-95.0 %) and for patients without LNM 97.1 % (95 % CI 95.9-98.2 %, hazard ratio = 3.21, 95 % CI 1.82-5.69, P < 0.001). In this population-based analysis, favorable cancer-specific survival rates were observed in nodal-negative and nodal-positive T1 rectal cancer patients after primary radical resection. The predictive value of tumor size, grading and age for LNM should be considered in medical decision making about local resection.
引用
收藏
页码:4405 / 4415
页数:11
相关论文
共 39 条
  • [1] Accuracy of High-Resolution Magnetic Resonance Imaging in Preoperative Staging of Rectal Cancer
    Akasu, Takayuki
    Iinuma, Gen
    Takawa, Masashi
    Yamamoto, Seiichiro
    Muramatsu, Yukio
    Moriyama, Noriyuki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (10) : 2787 - 2794
  • [2] Transanal Minimally Invasive Surgery (TAMIS) for Local Excision of Benign Neoplasms and Early-stage Rectal Cancer: Efficacy and Outcomes in the First 50 Patients
    Albert, Matthew R.
    Atallah, Sam B.
    deBeche-Adams, Teresa C.
    Izfar, Seema
    Larach, Sergio W.
    [J]. DISEASES OF THE COLON & RECTUM, 2013, 56 (03) : 301 - 307
  • [3] Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II)
    Andersson, J.
    Abis, G.
    Gellerstedt, M.
    Angenete, E.
    Angeras, U.
    Cuesta, M. A.
    Jess, P.
    Rosenberg, J.
    Bonjer, H. J.
    Haglind, E.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 (10) : 1272 - 1279
  • [4] Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
    Aschele, Carlo
    Cionini, Luca
    Lonardi, Sara
    Pinto, Carmine
    Cordio, Stefano
    Rosati, Gerardo
    Artale, Salvatore
    Tagliagambe, Angiolo
    Ambrosini, Giovanni
    Rosetti, Paola
    Bonetti, Andrea
    Negru, Maria Emanuela
    Tronconi, Maria Chiara
    Luppi, Gabriele
    Silvano, Giovanni
    Corsi, Domenico Cristiano
    Bochicchio, Anna Maria
    Chiaulon, Germana
    Gallo, Maurizio
    Boni, Luca
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) : 2773 - 2780
  • [5] A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer
    Bach, S. P.
    Hill, J.
    Monson, J. R. T.
    Simson, J. N. L.
    Lane, L.
    Merrie, A.
    Warren, B.
    Mortensens, N. J. McC.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (03) : 280 - 290
  • [6] Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - A meta-analysis
    Bipat, S
    Glas, AS
    Slors, FJM
    Zwinderman, AH
    Bossuyt, PMM
    Stoker, J
    [J]. RADIOLOGY, 2004, 232 (03) : 773 - 783
  • [7] Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions
    Bosch, Steven L.
    Teerenstra, Steven
    de Wilt, Johannes H. W.
    Cunningham, Chris
    Nagtegaal, Iris D.
    [J]. ENDOSCOPY, 2013, 45 (10) : 827 - 834
  • [8] LOCALLY WEIGHTED REGRESSION - AN APPROACH TO REGRESSION-ANALYSIS BY LOCAL FITTING
    CLEVELAND, WS
    DEVLIN, SJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1988, 83 (403) : 596 - 610
  • [9] Low Anterior Resection Syndrome Score Development and Validation of a Symptom-Based Scoring System for Bowel Dysfunction After Low Anterior Resection for Rectal Cancer
    Emmertsen, Katrine J.
    Laurberg, Soren
    [J]. ANNALS OF SURGERY, 2012, 255 (05) : 922 - 928
  • [10] Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
    Flanigan, RC
    Salmon, SE
    Blumenstein, BA
    Bearman, SI
    Roy, V
    McGrath, PC
    Caton, JR
    Munshi, N
    Crawford, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1655 - 1659